Science: Novo Nordisk Foundation establishes fellowships with Weizmann Institute (Israel), Stanford, MIT and Oxford.

“The Novo Nordisk Foundation is expanding and extending its Interdisciplinary Postdoctoral Fellowship Programme, thereby enabling ambitious researchers in the natural and technical sciences and life sciences to boost their careers with a research stay at one of several top international universities.

The Novo Nordisk Foundation wants to give researchers in Denmark the opportunity to seek inspiration and acquire new knowledge and skills by supporting their research stays at top international research institutions.

To facilitate this, the Foundation has just entered into strategic partnerships with several internationally leading research actors. This especially benefits the Foundation’s Interdisciplinary Postdoctoral Fellowship Programme.

A new programme budget of DKK 96 million over a 3-year period will boost the Programme while offering attractive fellowships with improved benefits and research opportunities at one of these top international universities.

The Foundation launched the Interdisciplinary Postdoctoral Fellowship Programme in 2015 through collaboration with Stanford Bio-X (USA). The fruitful experience has led to the expansion of the Programme, and the decision of the Foundation to establishing collaboration agreements with Massachusetts Institute of Technology (MIT, USA), the University of Oxford (United Kingdom) and the Weizmann Institute of Science (Israel), in addition to Stanford Bio-X.

The purpose of the Programme is to boost the professional and personal development of talented researchers through 3 years of international experience and networking in a world-leading research community. In addition to the career-promoting aspect for the individual researcher, the Programme has the additional benefit that it facilitates the researcher’s reintegration into the Danish research environment by supporting the fourth and final year of the project period at their affiliated university in Denmark and thus brings back innovation, networks and experience. (…)”

Press Release by Novo Nordisk Foundation, selected, shortend by VonNaftali